NO995620D0 - Antiviral combinations containing carbocyclic nucleoside 1592U89 - Google Patents

Antiviral combinations containing carbocyclic nucleoside 1592U89

Info

Publication number
NO995620D0
NO995620D0 NO995620A NO995620A NO995620D0 NO 995620 D0 NO995620 D0 NO 995620D0 NO 995620 A NO995620 A NO 995620A NO 995620 A NO995620 A NO 995620A NO 995620 D0 NO995620 D0 NO 995620D0
Authority
NO
Norway
Prior art keywords
combinations containing
carbocyclic nucleoside
containing carbocyclic
antiviral combinations
antiviral
Prior art date
Application number
NO995620A
Other languages
Norwegian (no)
Other versions
NO995620L (en
Inventor
David Walter Barry
Clair Martha Heider St
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9709945.1A external-priority patent/GB9709945D0/en
Priority claimed from GBGB9719883.2A external-priority patent/GB9719883D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO995620D0 publication Critical patent/NO995620D0/en
Publication of NO995620L publication Critical patent/NO995620L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
NO995620A 1997-05-17 1999-11-16 Antiviral combinations containing carbocyclic nucleoside 1592U89 NO995620L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9709945.1A GB9709945D0 (en) 1997-05-17 1997-05-17 A novel salt
GBGB9719883.2A GB9719883D0 (en) 1997-09-19 1997-09-19 Antiviral combinations
PCT/EP1998/002836 WO1998052570A1 (en) 1997-05-17 1998-05-14 Antiviral combinations containing the carbocyclic nucleoside 1592u89

Publications (2)

Publication Number Publication Date
NO995620D0 true NO995620D0 (en) 1999-11-16
NO995620L NO995620L (en) 2000-01-14

Family

ID=26311543

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995620A NO995620L (en) 1997-05-17 1999-11-16 Antiviral combinations containing carbocyclic nucleoside 1592U89

Country Status (12)

Country Link
EP (1) EP0979082A1 (en)
JP (1) JP2001525839A (en)
AR (1) AR012702A1 (en)
AU (1) AU7912398A (en)
BR (1) BR9809127A (en)
CA (1) CA2289655A1 (en)
CO (1) CO4950569A1 (en)
HR (1) HRP980264A2 (en)
MA (1) MA26496A1 (en)
NO (1) NO995620L (en)
PE (1) PE74799A1 (en)
WO (1) WO1998052570A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP990030A2 (en) * 1998-02-17 1999-10-31 Michael B. Maurin Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors
EP1332757B1 (en) * 1998-05-27 2012-06-13 Merck Sharp & Dohme Corp. Efavirenz compressed tablet formulation
US20010014352A1 (en) 1998-05-27 2001-08-16 Udit Batra Compressed tablet formulation
CO5070643A1 (en) * 1998-05-27 2001-08-28 Merck & Co Inc FORMULATION IN COMPRESSED TABLETS
WO2013111147A1 (en) * 2011-12-19 2013-08-01 Hetero Research Foundation Extended release compositions of nevirapine
EP2962693B1 (en) * 2013-02-27 2019-01-09 Kyoto University Pharmaceutical composition comprising abacavir for the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9417249D0 (en) * 1994-08-26 1994-10-19 Wellcome Found A novel salt
MY115461A (en) * 1995-03-30 2003-06-30 Wellcome Found Synergistic combinations of zidovudine, 1592u89 and 3tc

Also Published As

Publication number Publication date
HRP980264A2 (en) 1999-02-28
JP2001525839A (en) 2001-12-11
CO4950569A1 (en) 2000-09-01
MA26496A1 (en) 2004-12-20
PE74799A1 (en) 1999-08-13
NO995620L (en) 2000-01-14
AU7912398A (en) 1998-12-11
BR9809127A (en) 2000-08-01
WO1998052570A1 (en) 1998-11-26
AR012702A1 (en) 2000-11-08
CA2289655A1 (en) 1998-11-26
EP0979082A1 (en) 2000-02-16

Similar Documents

Publication Publication Date Title
ATE231874T1 (en) ANTIVIRAL PURINE DERIVATIVES
NO20006520L (en) adenosine
ATE231508T1 (en) AZYCLIC NUCLEOSIDE DERIVATIVES
ITTV970086A0 (en) SKATE STRUCTURE
NO954880D0 (en) Cytidine deaminase
NO992103L (en) Dihydropyrones with enhanced antiviral activity
DE59706609D1 (en) vice
DK1140937T3 (en) Antiviral nucleoside analogues
DE59703056D1 (en) Vice
NO995620D0 (en) Antiviral combinations containing carbocyclic nucleoside 1592U89
NO20011358L (en) Antiviral combinations
DK1054867T3 (en) Antiviral agents
DE59809171D1 (en) Screwing
FR2758108B3 (en) NOTEPAD
NO995621D0 (en) Antiviral combinations containing carbocyclic nucleoid 1592U89
FI964468A0 (en) adenosine
IT1295600B1 (en) CLOCK STRUCTURE
DE29709776U1 (en) Pen
SE9704147D0 (en) Nucleosides
DE29710177U1 (en) hourglass
DE29704944U1 (en) footstool
NO993562D0 (en) Gemcitabine derivatives
SE9703326D0 (en) lunch Page
FI972271A0 (en) Hollow to dryckesburk or annat dryckeskaerl
UA1615S (en) MEMBER CITY BUS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application